» Articles » PMID: 27539615

Individual Differences in Physical Symptom Burden and Psychological Responses in Individuals with Chronic Lymphocytic Leukemia

Overview
Journal Ann Hematol
Specialty Hematology
Date 2016 Aug 20
PMID 27539615
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic lymphocytic leukemia (CLL) is an incurable illness, with some patients requiring no treatment until disease progression. Burden from physical symptoms has been associated with depression, anxiety, and stress in cancer patients. Additionally, patient factors, i.e., individual differences, have been associated with worse psychological outcomes. There are few psychological studies of CLL, with no examination of individual differences. A cross-sectional design studied the covariation of symptom burden with depressive and anxiety symptoms and cancer-specific stress, and tested patients' individual differences as predictors and as moderators. CLL patients (N = 112) receiving active surveillance participated. They were Caucasian (100 %) and predominately male (55 %) with a mean age of 61; most (62.5 %) had stage 0 disease. A composite measure of physical symptom burden (CLL symptoms, fatigue, pain, impaired functional status) was tested as a predictor of psychological responses. Individual differences in psychiatric history and social support were tested as moderators. Using multiple linear regression, greater symptom burden covaried with higher levels of depressive and anxiety symptoms and cancer stress (ps < .05). Those with a psychiatric history, low social support, and low relationship satisfaction with one's partner reported greater symptom burden and more psychological symptoms and stress (ps < .05). Findings suggest that CLL patients in surveillance with a psychiatric history and/or low social support are at risk for greater distress when coping with high symptom burden. These new data clarify the experience of CLL surveillance and identify characteristics of patients with heightened risk for symptom burden, stress, and anxiety or depressive symptoms.

Citing Articles

Symptom clusters and self-management experiences of cervical cancer patients undergoing concurrent chemoradiotherapy: a qualitative study.

Song Z, Liu X, Jiang J, Yan X, Duan X Support Care Cancer. 2025; 33(3):187.

PMID: 39945910 DOI: 10.1007/s00520-025-09232-z.


Examining anxiety and depression in haematology cancer patients in ongoing treatment and under watchful waiting: A systematic review and meta-analysis.

Russell K, Moghaddam N, Tickle A Eur J Cancer Care (Engl). 2022; 31(6):e13678.

PMID: 35977801 PMC: 9787612. DOI: 10.1111/ecc.13678.


A Comprehensive Analysis of the Cancer Chronic Pain Experience: A Narrative Review.

Filipponi C, Masiero M, Pizzoli S, Grasso R, Ferrucci R, Pravettoni G Cancer Manag Res. 2022; 14:2173-2184.

PMID: 35855762 PMC: 9288227. DOI: 10.2147/CMAR.S355653.


Understanding the Psychological, Physiological, and Genetic Factors Affecting Precision Pain Medicine: A Narrative Review.

Chadwick A, Frazier A, Khan T, Young E J Pain Res. 2021; 14:3145-3161.

PMID: 34675643 PMC: 8517910. DOI: 10.2147/JPR.S320863.


Psychological Stress Up-Regulates CD147 Expression Through Beta-Arrestin1/ERK to Promote Proliferation and Invasiveness of Glioma Cells.

Wang P, Wang Z, Yan Y, Xiao L, Tian W, Qu M Front Oncol. 2020; 10:571181.

PMID: 33178600 PMC: 7593686. DOI: 10.3389/fonc.2020.571181.


References
1.
Hann D, Jacobsen P, Azzarello L, Martin S, Curran S, Fields K . Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998; 7(4):301-10. DOI: 10.1023/a:1024929829627. View

2.
Dodd M, Cho M, Cooper B, Miaskowski C . The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs. 2009; 14(2):101-10. PMC: 2831160. DOI: 10.1016/j.ejon.2009.09.005. View

3.
Mendoza T, Wang X, Lu C, Palos G, Liao Z, Mobley G . Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist. 2011; 16(2):217-27. PMC: 3228083. DOI: 10.1634/theoncologist.2010-0193. View

4.
Prieto J, Blanch J, Atala J, Carreras E, Rovira M, Cirera E . Stem cell transplantation: risk factors for psychiatric morbidity. Eur J Cancer. 2006; 42(4):514-20. DOI: 10.1016/j.ejca.2005.07.037. View

5.
Hallek M, Cheson B, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H . Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008; 111(12):5446-56. PMC: 2972576. DOI: 10.1182/blood-2007-06-093906. View